Clinical Study to Evaluate the Performance and Safety of the Clinical Decision Support System "EMBER" in Multiple Myeloma

Clinical Study to Evaluate the Performance and Safety of the Clinical Decision Support System "EMBER" in Multiple Myeloma - EMMO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038266

Enrollment

Registered

2026-07-20

Start date

2026-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90.0

Interventions

Group 1: Documentation of prospective healthcare provider decisions and evaluations

however, retrospective patient data is used and therefore has no impact on patient treatment.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Board certification in hematology and oncology

Exclusion criteria

Exclusion criteria: Member of the expert panel

Design outcomes

Primary

Measure	Time frame
Alignment with guidelines recommendations between specialist physicians and EMBER with the gold standard & average time for treatment decision	—

Secondary

Measure	Time frame
Error rate in score calculation (R-ISS, high-risk cytogenetics, elevated LDH and renal insufficiency) & usability (conformity with IEC 62366-1, see MDCG-2020-1) using System Usability Scale (SUS) Questionnaire	—

Countries

Germany

Contacts

Public ContactBeatrice Berneck

Klinik und Poliklinik für Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie

beatrice.berneck@medizin.uni-leipzig.de+499713203

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026